
Itero Biopharmaceuticals Private Limited
About Itero Biopharmaceuticals Private Limited
Data last updated:
Itero Biopharmaceuticals Private Limited was a foreign private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 13 February 2008.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008FTC057579.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Jagannath Venkat Samavedam and Ravi Babulal Jain.
Its last annual general meeting (AGM) was held on 30 September 2011, and its latest financial statements are for the year ended 31 March 2011. The registered office was at Hyderabad, Telangana.
Company details
CIN history
Itero Biopharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2008FTC057579. The current CIN is U24232TG2008FTC057579, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008FTC057579 | Current |
| U24232AP2008FTC057579 | Previous |
Contact details
Itero Biopharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressVentureast Plaza Plot No 40 & 41 Sy.No.115/1 Financial District Nanakramguda Gachi, Bowli Post, Hyderabad, Telangana, India – 500032
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Itero Biopharmaceuticals Private Limited
FY 2011 filings availableFinancial Statement Summary
| Metrics | FY 2010-11 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2010-11 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Itero Biopharmaceuticals Private Limited, buy the company report.
Board of directors of Itero Biopharmaceuticals Private Limited
Itero Biopharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagannath Venkat Samavedam | Director | 30 Sep 2014 | 12 Years 1 Months | As last reported |
| Ravi Babulal Jain Also directs: Geny Medium Labs Private Limited, Zmot Pro Pvt.Limited | Additional Director | 31 May 2012 | 14 Years 5 Months | As last reported |
Legal cases
No court or tribunal cases involving Itero Biopharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Itero Biopharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Itero Biopharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Itero Biopharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Jagannath Venkat Samavedam was appointed as Director on 30 Sep 2014.
Frequently asked questions
Itero Biopharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Itero Biopharmaceuticals was a foreign private limited company based in Hyderabad, Telangana, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 13 February 2008 and is registered under CIN U24232TG2008FTC057579. The company has been struck off by the Registrar of Companies and is no longer operational.
Itero Biopharmaceuticals had 2 directors:
- Jagannath Venkat Samavedam - Director
- Ravi Babulal Jain - Additional Director
The CIN (Corporate Identification Number) of Itero Biopharmaceuticals is U24232TG2008FTC057579. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Itero Biopharmaceuticals is at Ventureast Plaza Plot No 40 & 41 Sy.No.1151 Financial District Nanakramguda Gachi, Bowli Post, Hyderabad, Telangana, India – 500032.
Itero Biopharmaceuticals was incorporated on 13 February 2008. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Itero Biopharmaceuticals on record with the MCA are for the year ended 31 March 2011. Its last annual general meeting was held on 30 September 2011. Year-wise statements from 2015 are in the company report.
Itero Biopharmaceuticals operated in the life sciences industry, in the biotechnology segment. It worked in this industry before it was struck off.
Jagannath Venkat Samavedam was appointed as Director on 30 Sep 2014. Ramesh Alur ceased to be Director on 30 Sep 2014. Aditya Kapil ceased to be Director on 31 May 2012. Itero Biopharmaceuticals has 4 board changes on record in total.
Itero Biopharmaceuticals can be reached at its registered office: Ventureast Plaza Plot No 40 & 41 Sy.No.1151 Financial District Nanakramguda Gachi, Bowli Post, Hyderabad, Telangana, India – 500032.

